In a recent Perspective article (Toxicologic Pathology 31: 260-262, 2003) Waddell asserts that he has developed a log linear extrapolation model that can demonstrate a threshold and resolve for once and for all the uncertainies associated with low dose cancer risk extrapolation. However, his method essentially forces, rather than demonstrates, a threshold, and has many serious flaws that result in significant under-estimation of low dose risk. It would be a serious mistake for the scientific community to adopt Waddell's log linear extrapolation model for chemical carcinogenesis risk assessment.
Risk assessment is a complex scientific issue, and a variety of different models, both threshold and non-threshold, have been proposed for extrapolating risk from high to low doses in long term animal carcinogenicity studies. In a series of papers (4) (5) (6) (7) (8) , including a Perspective article in this journal (8) , William Waddell presents and discusses one particular threshold-based extrapolation model. However, he (i) apparently has the mistaken belief that if a model fits the data well in the observed range, it can be extrapolated to much lower doses to "unequivocally demonstrate" a threshold; (ii) apparently does not realize that his model is structured in a manner that essentially forces, rather than demonstrates, a threshold; and (iii) erroneously believes that by rescaling the dose and using a log linear model, he has achieved an important scientific breakthrough that once and for all resolves the threshold issue in chemical carcinogenesis. Waddell asserts that "the controversy over whether animal experiments demonstrate a threshold for carcinogenicity from chemicals" is due to nothing more than "an error in plotting dose-response" (8) . This is a rather simplistic view of the extrapolation issue.
Consider Waddell's extrapolation procedure. First, he expresses dose in terms of molecules of carcinogen/kg/day. Despite Waddell's claims that this rescaling, which he attributes to Rozman et al. (3) , is a "brilliant concept" (5) and one that is "enormously important" (8) , it is simply a conversion of dose from one scale of measure to another. Nothing more.
Waddell then assumes a log-linear model, i.e., that the relationship between the carcinogenic response and log dose is linear. Since mathematically it is not possible to take the log of zero, Waddell assumes that the control tumor response is known without error and subtracts it from each dosed group response. He then carries out a linear regression, extrapolating the line to zero response above background, which is assumed to be the threshold dose.
Waddell justifies his approach by citing impressivesounding concepts like the "thermodynamic concept of chemical potential and the law of mass action" (8) and "Avogadro's constant" (4). However, he never explains how these "laws of nature" justify his view that a log linear model reflects the underlying mechanisms of carcinogenesis for all tumor sites, all chemicals, and all animal models. The real issue is not a better understanding of the "fundamental laws of chemistry" and a rescaling of the dose as Waddell claims (5, 8) . Rather, it is a better understanding of the carcinogenic process itself and a greater appreciation of the uncertainties associated with low dose extrapolations.
Waddell further justifies his extrapolation model by arguing (4-8) that for selected chemicals it provides a good fit for data in the observed range. However, a variety of models may fit the data equally well in the observed data region and yet produce very different estimates of carcinogenic risk for low doses. The key scientific issue concerns the shape of the dose-response curve in the low dose region, and this is unknown. Thus, any extrapolation from Waddell's model to carcinogenic risks at lower doses has all the pitfalls and uncertainties of extrapolations of any other model.
Waddell claims (6) that his extrapolation model can "unequivocally demonstrate" a threshold. However, it is impossible to "prove" that there is no increased risk associated with a given dose. Even if no increased response is evident at that dose, a slightly elevated risk above background may exist. It is well recognized (1, 2) that there is just not enough power for the sample sizes typically used in long term rodent carcinogenicity studies to detect subtle carcinogenic effects.
Rather than demonstrating a threshold, Waddell's extrapolation model essentially forces a threshold, except for rare cases in which all doses show identical carcinogenic responses, so the dose-response curve is flat and parallel to the x axis. In all other cases, a straight line must intersect the x axis, and that point of intersection using the Waddell model is his threshold dose.
Even Waddell concedes that his log-linear model breaks down in the low dose region, arguing that "any further extrapolation" below the purported threshold dose is "completely unwarranted" (4) . Further extrapolation would imply that doses below the threshold dose are actually protective against carcinogenesis. However, Waddell's pronouncement that it is scientifically defensible to extrapolate his model precisely to the x axis and then completely inappropriate to extrapolate further is pure speculation. In fact, the point at which his extrapolation fails is completely unknown, and could easily be well above the x axis, in which case the purported threshold dose is meaningless.
Four other questionable features of the Waddell extrapolation model are discussed below.
I. WADDELL CLAIMS THAT HIS MODEL CAN DEMONSTRATE A THRESHOLD EVEN FOR CHEMICALS
SHOWING SIGNIFICANT CARCINOGENIC EFFECTS AT ALL DOSE LEVELS In discussions of thresholds, arguments often center on whether or not an apparent non-response at a low dose is or is not evidence of a threshold. However, to my knowledge, no one before has ever claimed that a threshold can be unequivocally demonstrated even if there is a highly significant carcinogenic response at all doses evaluated. However, Waddell's approach can purportedly demonstrate "unequivocal thresholds" in these cases.
For example, consider the NTP primidone study, in which liver carcinoma rates in male mice were 12/50, 31/50, 35/50 and 38/50 for control, low, mid, and high dose groups respectively. The increased liver tumor incidence at the low dose is highly significant (p < 0.001). Nevertheless, Waddell claims (7) that a log linear model extrapolation can unequivocally demonstrate a threshold for these data. However, in my view, establishing a meaningful and unequivocal threshold dose in cases such as this is impossible.
II. WADDELL SUBJECTIVELY DISCARDS DATA POINTS,
MOST NOTABLY IN THE LOW DOSE REGION When estimating low dose risks, the observed tumor responses at relatively low doses are important. Since carcinogenic risks at such doses may be relatively small, it is not uncommon to see slightly elevated tumor rates above background at these doses. Waddell removes low level responses from his extrapolation by assuming that such marginally elevated tumor rates are simply reflecting "experimental variability" (5) .
For example, in many of his ED01 paper extrapolations (5), Waddell deletes from his model fit marginally elevated tumor responses at low doses "because they were less than 1% above the control values." He argues that this "can be justified on the basis of experimental variability." I disagree. One consequence of Waddell's dismissing marginally elevated tumor responses as random variability and ignoring them in his extrapolation is that his resulting threshold dose for some chemicals is actually greater than a dose that shows an elevated tumor response over background (5)! Thus, this subjective discarding of data points will likely result in significant under-estimation of carcinogenic risk.
III. WADDELL'S MODEL ASSUMES THAT THE CONTROL TUMOR RATE AND THE RESULTING THRESHOLD DOSE
ARE KNOWN WITHOUT ERROR Although Waddell uses the "experimental variability" argument to dismiss marginally elevated tumor rates in low dose groups, he assumes that the control tumor rate is known without error. However, the observed control response is an estimate of the underlying population tumor rate, and the "experimental variability" associated with this estimated background rate should be taken into account in any extrapolation model. The Waddell approach does not do this.
Moreover, virtually all of the commonly used extrapolation methods recognize that there is some uncertainty in the estimate of the dose producing a specified low risk above background. In fact, most regulatory agencies require the calculation of some measure of uncertainty in low dose extrapolations. I could find no corresponding discussion of the uncertainty of the estimated threshold dose using the Waddell extrapolation model.
IV. WADDELL CLAIMS THAT HIS MODEL CAN DEMONSTRATE A THRESHOLD BASED ON ONLY TWO DOSES
One common criticism of standard approaches to risk assessment is that not enough doses are used to characterize the shape of the dose-response curve. However, Waddell claims to be able to establish an unequivocal threshold with only two doses. He simply log-transforms the doses, subtracts out the background rate, connects the dots (with a resulting correlation of 1.000, since the fit is perfect, just as it would have been without the log transformation), and extrapolates the line down to zero response over background.
Waddell presents several examples of "unequivocal thresholds" derived from an extrapolation of carcinogenic risk from two data points. He emphasizes (5) that the two data points should be "reliable" (whatever that means), but it is just not possible to establish an unequivocal threshold based on two data points, especially when the low dose response remains far above control levels.
To illustrate the dangers associated with Waddell's log linear extrapolation model, assume that a carcinogen produces a dose-response curve that is linear in dose. Further, assume a zero background rate and "reliable" tumor rates of 45% and 90% associated with doses of x and 2x molecules of carcinogen/kg/day respectively. In this case, both a linear model and Waddell's log linear model fit the data perfectly, but an extrapolation of Waddell's model "unequivocally demonstrates" a threshold dose of 0.5x, a dose that is associated with an actual tumor rate of 22.5%! Obviously, such an extrapolation lacks scientific credibility and would have disastrous public health consequences.
Many other examples could be given with more than two doses, with different assumed shapes of the dose-response curve, and with different tumor responses, that produce similar results. The point is that based on model fit in the observed dose range, it may be impossible to differentiate between two models that produce quite different estimates of low dose risk. And among competing extrapolation models, Waddell's log linear model is arguably the worst possible choice from the standpoint of protecting public health.
To summarize, the most important differences between Waddell's approach and other extrapolation methods are that Waddell's extrapolation procedure (i) is a model that essentially forces a threshold; (ii) assumes the control response is known without error; (iii) ignores the uncertainty of the extrapolated threshold estimate; (iv) subjectively discards datapoints from the extrapolation, including potentially important tumor responses at low doses; (v) purportedly can unequivocally demonstrate thresholds even when all dosed groups show highly significant carcinogenic effects; (vi) purportedly can unequivocally demonstrate thresholds with as few as two doses; (vii) fails at some unknown point in the low dose region, possibly well above the purported threshold dose; and (viii) demonstrably can significantly under-estimate low dose risk.
In conclusion, because of the many problems discussed above, in my view it would be a serious mistake for the scientific community to adopt Waddell's log linear extrapolation model for chemical carcinogenesis risk assessment.
